Related references
Note: Only part of the references are listed.Fatty liver incidence and predictive variables
Akira Tsuneto et al.
HYPERTENSION RESEARCH (2010)
Proteomics analysis of cardiac muscle from rats with peroxisomal proliferator-activated receptor α (PPARα) stimulation
Masafumi Miyazaki et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2010)
A genome-wide perspective of genetic variation in human metabolism
Thomas Illig et al.
NATURE GENETICS (2010)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Anna Kotronen et al.
GASTROENTEROLOGY (2009)
Genetic polymorphisms in non-alcoholic fatty liver disease: Clues to pathogenesis and disease progression
Marko Duvnjak et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes
Xin Yuan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes
Kasper Lage et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
Massimo Pinzani et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Nonalcoholic fatty liver disease as a complication of insulin resistance
Manal F. Abdelmalek et al.
MEDICAL CLINICS OF NORTH AMERICA (2007)
A Bayesian multilocus association method: Allowing for higher-order interaction in association studies
Anders Albrechtsen et al.
GENETICS (2007)
Fatty liver and the metabolic syndrome
Brent A. Neuschwander-Tetri
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Relationships between the functional PPARα Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people
Thomas Sparso et al.
MOLECULAR GENETICS AND METABOLISM (2007)
FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization
Hsiang-Yu Yuan et al.
NUCLEIC ACIDS RESEARCH (2006)
Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver
Yuichi Harano et al.
LIVER INTERNATIONAL (2006)
Proteomic characterization of the effects of clofibrate on protein expression in rat liver
JF Léonard et al.
PROTEOMICS (2006)
A gene atlas of the mouse and human protein-encoding transcriptomes
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats -: Comparison with PPAR-γ activation
JM Ye et al.
DIABETES (2001)
Roles of PPARs in health and disease
S Kersten et al.
NATURE (2000)
Prevalence of and risk factors for hepatic steatosis in northern Italy
S Bellentani et al.
ANNALS OF INTERNAL MEDICINE (2000)
The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening
T Lauritzen et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
